AI | pharmaphorum

AI

Events

Reuters Pharma 2022 - a day one overview - part 1

The Reuters Pharma event 2022 began as a bustling industry affair yesterday, based out of the Nice Acropolis convention centre on France’s balmy south coast.

Views & Analysis

Moving to component management & traceability: progress, bar...

Component management is fairly new to the regulatory market, with pharmaceutical firms moving from traditional document management systems to more dynamic component content management syste

Views & Analysis

AI diagnostics tools and oncology: predicting patient outcom...

AI French-American biotech start-up Owkin recently published new research in

Views & Analysis

Transforming oncology outcomes through data and digital

The healthcare industry is evolving rapidly, with data and digital technologies transforming everyday communications as we know them.

Oncology

AI-derived cancer vaccines: the pharmaphorum podcast

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science off

News

Atomwise founders Abraham Heifets and Izar Wallach.

Diving deeper into AI discovery, Sanofi signs 5-drug deal wi...

Sanofi is tapping San Francisco-based Atomwise for a new AI-fuelled drug discovery deal, paying $20 million for five new drug targets — and possibly spending more than a billion in mileston

Reuters Pharma 2022 - a day one overview - part 1

Moving to component management & traceability: progress, bar...

AI diagnostics tools and oncology: predicting patient outcom...

Transforming oncology outcomes through data and digital

AI-derived cancer vaccines: the pharmaphorum podcast

Diving deeper into AI discovery, Sanofi signs 5-drug deal wi...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

AI

Editor's Picks